GL1X · GenesisL1 explorer

UniProt Q20BJ8

Cystic fibrosis transmembrane conductance regulator (Q20BJ8)

Cystic fibrosis transmembrane conductance regulator (UniProt Q20BJ8), EC 3.6.3.49, 5.6.1.6: 12 experimental structures on GenesisL1, 4 ligands bound, 14 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q20BJ8
Protein
Cystic fibrosis transmembrane conductance regulator
EC
3.6.3.49, 5.6.1.6
Experimental structures
12
Predicted models
0
Ligands
4
Pockets
14 · 3 records with a druggable one

Structures

12 records of Q20BJ8 in the MolNFT archive: 12 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
6GJQhuman NBD1 of CFTR in complex with nanobody T27x-ray diffractionA, C, E, GATP—
6GJQHuman NBD1 of cftr in complex with nanobody T27x-ray diffractionA, C, E, GATP—
6GJSHuman NBD1 of CFTR in complex with nanobodies D12 and T4x-ray diffractionAMG, ATP6 (best 0.67)
6GJSHuman NBD1 of cftr in complex with nanobodies D12 and T4x-ray diffractionAMG, ATP—
6GJUhuman NBD1 of CFTR in complex with nanobodies T2a and T4x-ray diffractionA—6 (best 0.68)
6GJUHuman NBD1 of cftr in complex with nanobodies T2A and T4x-ray diffractionA——
6GK4Human NBD1 of CFTR in complex with nanobodies D12 and T8x-ray diffractionA, DMG, ATP—
6GK4Human NBD1 of cftr in complex with nanobodies D12 and T8x-ray diffractionA, DMG, ATP—
6GKDhuman NBD1 of CFTR in complex with nanobodies D12 and G3ax-ray diffractionA, F, I, L, O, RGLC, Z9N, ATP, MG—
6GKDHuman NBD1 of cftr in complex with nanobodies D12 and G3Ax-ray diffractionA, F, I, L, O, RGLC, Z9N, ATP, MG—
6ZE1human NBD1 of CFTR in complex with nanobody G11ax-ray diffractionAATP2 (best 0.52)
6ZE1Human NBD1 of cftr in complex with nanobody G11Ax-ray diffractionAATP—

Ligands

  • ATP · Adenosine-5'-triphosphate · in 10 records
  • MG · Magnesium ion · in 6 records
  • GLC · alpha-D-glucopyranose · in 2 records
  • Z9N · alpha-D-fructofuranose · in 2 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.